The neural retina in retinopathy of prematurity

Ronald M Hansen1, Anne Moskowitz1, James D Akula1

  • 1Department of Ophthalmology, Children's Hospital and Harvard Medical School, 300 Longwood Ave., Boston, MA 02115-5737, USA.

Insights

Retinopathy of prematurity (ROP) causes long-term vision problems. Studies show persistent rod dysfunction and retinal changes years after ROP, suggesting new light-based management strategies.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Developmental Biology

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of vision impairment in premature infants.
  • ROP is a neurovascular disorder with potential long-term visual consequences.
  • The role of rod photoreceptors in ROP pathogenesis and long-term outcomes is not fully understood.

Purpose of the Study:

  • To investigate the long-term functional and structural alterations in the neurosensory retina following ROP.
  • To explore the contribution of rod photoreceptors to the pathogenesis and persistent effects of ROP.
  • To evaluate potential noninvasive therapeutic strategies for ROP.

Main Methods:

  • Noninvasive electroretinography (ERG) to assess retinal function.
  • Psychophysical tests to evaluate visual thresholds in specific retinal regions.
  • Retinal imaging techniques to study retinal structure and photoreceptor morphology.

Main Results:

  • Persistent rod dysfunction and altered post-receptor responses were observed years after active ROP.
  • Mild and Severe ROP delayed parafoveal scotopic threshold maturation and attenuated cone-mediated ERG responses.
  • Significant thickening of post-receptor retinal laminae and dysmorphic cone photoreceptors were noted in the central retina.

Conclusions:

  • ROP leads to enduring functional and structural retinal changes, impacting both rod and cone systems.
  • These findings highlight the need for continued monitoring and suggest novel therapeutic avenues.
  • A proposal for noninvasive light-based management of ROP is presented, potentially complementing existing treatments.